Under the liquidity contract entrusted by Innate Pharma to Gilbert Dupont, the following assets appeared on the liquidity account as at December 31, 2015:
- 22,128 shares of Innate Pharma, and
- 358,336.72 euros in cash
As a reminder, at June 30, 2015, the following assets appeared on the liquidity account:
- 26,811 shares of Innate Pharma, and
- 334,840.22 euros in cash
| CP en français | 149.06 KB |
| PR in English | 150.89 KB |